KAM
Krensavage Asset Management Portfolio holdings
AUM
$189M
This Quarter Return
+9.24%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$313M
AUM Growth
+$313M
(+13%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
6.08%
Top 10 Holdings %
Top 10 Hldgs %
73.91%
Holding
24
New
1
Increased
20
Reduced
1
Closed
2
Top Buys
| 1 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$4.96M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
$4.89M |
| 3 |
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
|
$4.12M |
| 4 |
CONMED
CNMD
|
$2.4M |
| 5 |
United Therapeutics
UTHR
|
$2.33M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$8.22M |
| 2 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
$1.42M |
| 3 |
Innoviva
INVA
|
$1.26M |
Sector Composition
| 1 | Healthcare | 72.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $33.6M | 10.72% | 214,456 +14,883 | +7% | +$2.33M |
|
|
2
Enanta Pharmaceuticals
ENTA
$180M
| $29M | 9.25% | 878,446 +148,138 | +20% | +$4.89M |
|
|
BXLT
3
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $28.8M | 9.19% | 738,365 +16,565 | +2% | +$647K |
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $25.8M | 8.22% | 392,697 +19,635 | +5% | +$1.29M |
|
5
Orthofix Medical
OFIX
$592M
| $25.1M | 8.01% | 640,176 +29,929 | +5% | +$1.17M |
|
|
IPXL
6
DELISTED
Impax Laboratories, Inc.
IPXL
| $25M | 7.98% | 585,170 +54,295 | +10% | +$2.32M |
|
7
Avanos Medical
AVNS
$554M
| $18.9M | 6.02% | 564,952 +29,009 | +5% | +$969K |
|
8
Amgen
AMGN
$155B
| $17.5M | 5.58% | 107,763 +4,227 | +4% | +$686K |
|
|
9
CONMED
CNMD
$1.68B
| $14.5M | 4.62% | 329,011 +54,483 | +20% | +$2.4M |
|
10
Merck
MRK
$210B
| $13.5M | 4.3% | 255,044 +5,541 | +2% | +$293K |
|
|
SRGA
11
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $12.2M | 3.9% | 3,076,929 +1,248,257 | +68% | +$4.96M |
|
|
SCMP
12
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $9.61M | 3.07% | 555,652 +27,477 | +5% | +$475K |
|
|
AGN
13
DELISTED
Allergan plc
AGN
| $8.25M | 2.63% | 26,394 +2,154 | +9% | +$673K |
|
14
Assertio
ASRT
$80.4M
| $8.14M | 2.6% | 448,729 +73,342 | +20% | +$1.33M |
|
|
IVC
15
DELISTED
Invacare Corporation
IVC
| $7.36M | 2.35% | 423,280 +20,898 | +5% | +$363K |
|
|
SPPI
16
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $6.62M | 2.11% | 1,097,335 +18,833 | +2% | +$114K |
|
|
VXRT
17
DELISTED
Vaxart
VXRT
| $5.09M | 1.63% | 2,625,239 +54,662 | +2% | +$106K |
|
|
DSCI
18
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $4.12M | 1.31% | +901,834 | New | +$4.12M |
|
|
JNP
19
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $2.97M | 0.95% | 288,326 +8,609 | +3% | +$88.7K |
|
|
STRR
20
DELISTED
Star Equity Holdings
STRR
| $2.79M | 0.89% | 481,023 +23,324 | +5% | +$135K |
|
|
HRC
21
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.66M | 0.53% | 34,605 -171,108 | -83% | -$8.22M |
|
|
22
Innoviva
INVA
$1.29B
| – | – | -176,108 | Closed | -$1.26M |
|
|
FURX
23
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| – | – | -145,544 | Closed | -$1.42M |
|